GSK's Competitors, Revenue, Number of Employees, Funding and Acquisitions

GlaxoSmithKline discovers, develops and manufactures medicines, vaccines and consumer healthcare products.

GSK's headquar...
Read more

Annual Revenue

Employees

Emma Walmsley's photo - CEO of GSK

CEO

Emma Walmsley

CEO Approval Rating

71/100

OVERVIEW

Founded:

2000

Headquarters:

MiddlesexEngland

Status:

PublicIndependent Company of London Stock ExchangeGSK

Industry Sector:

Pharmaceuticals

SIC Code:

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Novartis a competitor of GSK?

Want more news like this in your inbox? Get access for free

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

Bristol Myers Squibb is perceived as one of GSK's biggest rivals. Bristol Myers Squibb was founded in 1858 in New York, New York. Bristol Myers Squibb is in the Pharmaceuticals field. Bristol Myers Squibb generates $15.5B less revenue than GSK.

Johnson & Johnson is GSK's #2 rival. Johnson & Johnson is a Public company that was founded in 1886 in New Brunswick, New Jersey. Johnson & Johnson competes in the Personal Products industry. Compared to GSK, Johnson & Johnson has 35,273 more employees.

Merck is one of GSK's top competitors. Merck's headquarters is in Kenilworth, New Jersey, and was founded in 1891. Like GSK, Merck also operates in the Pharmaceuticals industry. Merck generates 112% of GSK's revenue.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Emma Walmsley

CEO

- -
99,827
$0
$39.4B
1

Giovanni Caforio

Chairman & CEO

74/100
23,300
- -
$23.9B
2

Alex Gorsky

Chairman & CEO

66/100
135,100
- -
$81.3B
3

Kenneth C. Frazier

Chairman & CEO

59/100
69,000
- -
$44.4B
4

Vasant Narasimhan

CEO

81/100
118,393
- -
$50.3B
5

Miles D. White

Chairman & CEO

58/100
103,000
$6.9M
$30.9B
6

Severin Schwan

CEO

54/100
94,052
- -
$932.5M
7

David A. Ricks

Chairman & CEO

67/100
38,680
- -
$24.7B
8

Albert Bourla

CEO

60/100
92,400
- -
$53.7B
9

Umang Vohra

CEO

70/100
12,235
- -
$1.9B
10

Kaare Schultz

President & CEO

75/100
42,535
$5.5B
$17.7B

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$39.4B

GSK's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 33.6B. Over the last three quarters, GSK's revenue has grown by 11%. Specifically, in Q2 2019's revenue was $9.9B; in Q1 2019, it was $10B; in Q4 2018, it was $8.9B.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
TESARO, Inc.

Dec 2018

Source »
$5.1B
TESARO is a biopharmaceutical company that identifies, acquires, develops and commercializes cancer therapeutics.
Glycovaxyn AG

Feb 2015

Source »
$190M
GlycoVaxyn discovers, develops and manufactures next-generation bioconjugate vaccines.
Okairos Srl

May 2013

Source »
$325M
-
MaxiNutrition

Dec 2010

Source »
$255M
MaxiNutrition is a manufacturer and supplier of protein products for the athletes.
ViiV Healthcare

Nov 2009

Source »
undisclosed
ViiV Healthcare is a biotechnological company that develops therapies for human immunodeficiency virus.

These are all the companies that GSK has acquired. GSK has acquired 7 companies and its latest acquisition was TESARO, Inc. in Dec 2018. TESARO is a biopharmaceutical company that identifies, acquires, develops and commercializes cancer therapeutics.

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Save the Children is a non-profit organization that provides education and employment opportunities for economically backward children.
$1.5M
Jun 07, 2019
Grant
-
SpringWorks develops and commercializes clinical drug therapies for the treatment of cancer, oncology and rare genetic diseases.
$125M
Mar 31, 2019
Series B
Sep 13, 2019
Sitryx develops immunometabolic therapies for the treatment of cancer and autoimmune diseases.
$30M
Oct 07, 2018
Series A
-
23andMe operates as a personal genetics company that provides ancestry reports and genetic data analysis services.
$300M
Jul 24, 2018
Equity
-
eFFECTOR is a biopharmaceutical company that researches and develops small molecule therapeutics for the treatment of cancer.
$56M
Dec 10, 2015
Series B
-

These are all the companies that GSK has invested in. GSK has invested 7 companies and its latest investment was TESARO, Inc. in Dec 2018. TESARO is a biopharmaceutical company that identifies, acquires, develops and commercializes cancer therapeutics.

GSK News

October 10, 2019BioPortfolio

GSK adopts Lyells services to improve T cell fitness

GSK taps Lyells technology to delay exhaustion of T cells and will explore creating a new platform to... See more »
October 10, 2019BioPortfolio

Manufacturing 'Grand Challenge' targets pharma to develop continuous formulation platform

A new initiative will see the Centre for Process Innovation CPI work with the University of Strathcly... See more »
October 9, 2019The Pharma Letter

BRIEF-Two new formats of Nucala approved in Canada

UK pharma major GlaxoSmithKline's Nucala (mepolizumab) has been approved in Canada in two new formats... See more »
October 9, 2019FiercePharma

GSK joins other drugmakers recalling Zantac products

GlaxoSmithKline has decided that stopping distribution of its Zantac products just won't cut it. The ... See more »
October 9, 2019The Guardian

Zantac in global recall over 'unacceptable' levels of potential carcinogen

Heartburn medicine pulled by GlaxoSmithKline while it investigates source of impurityGlaxoSmithKline ... See more »
October 9, 2019BioPortfolio

GSK forms cell therapy R&D pact with starstudded biotech

Lyell Immunopharma working on ways to improve T cell function and fitness... See more »
October 8, 2019Reuters

UPDATE 1-GSK recalls popular heartburn medicine Zantac - U.K. medicines watchdog

GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a ... See more »

GSK Press Releases

March 28, 2019PR Newswire

Champion Baseball Pitcher Justin Verlander Signs on with FLONASE® Allergy Relief for a Second Season

WARREN, N.J., March 28, 2019 /PRNewswire/ -- GSK Consumer Healthcare and FLONASE® Allergy Relief, tod... See more »
March 27, 2019PRcom

These Next-Generation Procurement Tools Are Already Here

Experts from IBM, GlaxoSmithKline, and Source One to demonstrate game-changing solutions for procurem... See more »
February 16, 2019Dubai PR Network

GSK sets to improve antibiotic adherence in the UAE with a new patient-friendly chatbot

GSK launches Medzy, a new UAE patient-friendly chatbot, aimed at increasing antibiotic adherence This... See more »
January 2, 2019GlobeNewswire

Exagen enters second-year agreement with GSK to drive greater awareness about challenges facing lupus diagnosis and management

Albuquerque, NM and San Diego, CA, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Exagen, a leader in rheumatology... See more »
December 11, 2018StreetInsider

NeuroMetrix Reports Agreement with GSK Healthcare on 2019 Quell Joint Development Program and Modification to Strategic Collaboration

NeuroMetrix, Inc. (Nasdaq: NURO) today reported momentum in its strategic collaboration with GSK Cons... See more »
September 11, 2018PressReleasePoint

GSK data presented at ERS further supports its industry-leading respiratory medicines portfolio

GlaxoSmithKline plc (GSK) will profile the growing evidence base that supports its broad respiratory ... See more »
September 8, 2018PressReleasePoint

GSK receives complete response letter from US FDA for use of mepolizumab in COPD patients

GlaxoSmithKline plc (LSE/NYSE: GSK) today received a complete response letter (CRL) from the US FDA r... See more »

GSK Videos

Social Statistics

Headquarters

980 Great West Road Brentford

Middlesex, EnglandTW8 9GS

44-20-8047-5000

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

GlaxoSmithKline plc (LSE: GSK; NYSE: GSK) discovers, develops, manufactures pharmaceuticals, vaccines, and consumer health products. GSK is a British pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo W...

CEO

GSK's CEO, Emma Walmsley, currently has an approval rating of 71%. GSK's primary competitors are Bristol Myers Squibb, Johnson & Johnson & Merck.

Website

gsk.com

Frequently Asked Questions about GSK

  1. When was GSK founded?

    GSK was founded in 2000
  2. Who is GSK's CEO?

    GSK's CEO is Emma Walmsley
  3. How much revenue does GSK generate?

    GSK generates $39.4B in revenue
  4. How much funding does GSK have?

    GSK has historically raised $0 in funding
  5. Where is GSK's headquarters?

    GSK's headquarters is in Middlesex England, GB
  1. How many employees does GSK have?

    GSK has 99,827 employees
  2. What sector does GSK operate in?

    GSK is in Pharmaceuticals
  3. Who are GSK's competitors?

    GSK's top competitors are Bristol Myers Squibb, Johnson & Johnson, Merck
  4. Who has GSK invested in?

    GSK's has invested in companies such as Save the Children, SpringWorks, Sitryx